Effect of laparoscopic Roux-en-Y gastroenterostomy with BMI&lt;35 kg/m(2) in type 2 diabetes mellitus. (Q51355601)

4 April 2018

title

Effect of laparoscopic Roux-en-Y gastroenterostomy with BMI<35 kg/m(2) in type 2 diabetes mellitus. (English)

1 reference

4 April 2018

author name string

Liyong Zhu

1

1 reference

4 April 2018

Zhaohui Mo

2

1 reference

4 April 2018

Xiangwu Yang

3

1 reference

4 April 2018

Shengping Liu

4

1 reference

4 April 2018

Guohui Wang

5

1 reference

4 April 2018

Pengzhou Li

6

1 reference

4 April 2018

Juan Tan

7

1 reference

4 April 2018

Fei Ye

8

1 reference

4 April 2018

Jeff Strain

9

1 reference

4 April 2018

Ibrahim Im

10

1 reference

4 April 2018

Shaihong Zhu

11

1 reference

4 April 2018

publication date

1 October 2012

1 reference

4 April 2018

published in

Obesity Surgery

1 reference

4 April 2018

volume

22

1 reference

4 April 2018

issue

10

1 reference

4 April 2018

page(s)

1562-1567

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s11695-012-0694-0

exact match

0 references

cites work

Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Abdominal obesity and the prevalence of diabetes and intermediate hyperglycaemia in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Effects of obesity surgery on non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0694-0

Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22692669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Improvement and stabilization of chronic kidney disease after gastric bypass

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22692669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Revisional operations for marginal ulcer after Roux-en-Y gastric bypass

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22692669

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11695-012-0694-0

1 reference

4 April 2018

PubMed ID

22692669

1 reference

4 April 2018